Javascript must be enabled to continue!
Asthma severity identification from pulmonary acoustic signal for computerized decision support system
View through CrossRef
Abstract
Objective: Breath sound has information about underlying pathology and condition of subjects. The purpose of this study is to examine asthmatic acuteness levels (Mild, Moderate, Severe) using frequency features extracted from wheeze sounds. Further, analysis has been extended to observe behavior of wheeze sounds in different datasets.
Method: Segmented and validated wheeze sounds was collected from 55 asthmatic patients from the trachea and lower lung base (LLB) during tidal breathing maneuvers. Segmented wheeze sounds have been grouped in to nine datasets based on auscultation location, breath phases and a combination of phase and location. Frequency based features F25, F50, F75, F90, F99 and mean frequency (MF) has been calculated from normalized power spectrum. Subsequently, multivariate analysis has been performed for analysis.
Result: Generally frequency features observe statistical significance (p < 0.05) for the majority of datasets to differentiate severity level ? = 0.432-0.939, F(12, 196-1534) = 2.731-11.196, p < 0.05, ????2 = 0.061-0.568. It was observed that selected features performed better (higher effect size) for trachea related samples ? = 0.432-0.620, F(12, 196-498) = 6.575-11.196, p < 0.05, ????2 = 0.386-0.568.
Conclusion: The results demonstrate that severity levels of asthmatic patients with tidal breathing can be identified through computerized wheeze sound analysis. In general, auscultation location and breath phases produce wheeze sounds with different characteristics.
Keywords: Asthma, Breath Sounds, Wheeze Detection, Airway Obstruction, Severity Level
Continuous...
Pakistan Medical Association
Title: Asthma severity identification from pulmonary acoustic signal for computerized decision support system
Description:
Abstract
Objective: Breath sound has information about underlying pathology and condition of subjects.
The purpose of this study is to examine asthmatic acuteness levels (Mild, Moderate, Severe) using frequency features extracted from wheeze sounds.
Further, analysis has been extended to observe behavior of wheeze sounds in different datasets.
Method: Segmented and validated wheeze sounds was collected from 55 asthmatic patients from the trachea and lower lung base (LLB) during tidal breathing maneuvers.
Segmented wheeze sounds have been grouped in to nine datasets based on auscultation location, breath phases and a combination of phase and location.
Frequency based features F25, F50, F75, F90, F99 and mean frequency (MF) has been calculated from normalized power spectrum.
Subsequently, multivariate analysis has been performed for analysis.
Result: Generally frequency features observe statistical significance (p < 0.
05) for the majority of datasets to differentiate severity level ? = 0.
432-0.
939, F(12, 196-1534) = 2.
731-11.
196, p < 0.
05, ????2 = 0.
061-0.
568.
It was observed that selected features performed better (higher effect size) for trachea related samples ? = 0.
432-0.
620, F(12, 196-498) = 6.
575-11.
196, p < 0.
05, ????2 = 0.
386-0.
568.
Conclusion: The results demonstrate that severity levels of asthmatic patients with tidal breathing can be identified through computerized wheeze sound analysis.
In general, auscultation location and breath phases produce wheeze sounds with different characteristics.
Keywords: Asthma, Breath Sounds, Wheeze Detection, Airway Obstruction, Severity Level
Continuous.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
Hubungan Tingkat Pengetahuan Mengenai Asma dengan Tingkat Kontrol Asma
Hubungan Tingkat Pengetahuan Mengenai Asma dengan Tingkat Kontrol Asma
AbstrakKontrol gejala asma yang baik merupakan tujuan pengobatan bagi pasien asma. Pengobatan medikamentosa dan self management dibutuhkan untuk mencapai kontrol asma. Pengobatan m...

